AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

CPRX(Delisted)

Catalyst·NASDAQ
--
--(--)

Catalyst (CPRX) Company Profile

Catalyst Pharmaceuticals, Inc.

A commercial-stage biopharmaceutical company that develops prescription drugs for neuromuscular and neurological diseases and disorders

--
--
11/08/2006
NASDAQ Stock Exchange
182
12-31
Common stock
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134
Develops and commercializes medicines.
Catalyst Pharmaceuticals, Inc., was incorporated in Delaware in July 2006. The Company is a commercial-stage, patient-centric biopharmaceutical company focused on the licensing, development and commercialization of new high-quality medicines for patients with rare and difficult-to-treat diseases. The company uses a concerted and diligent effort to find therapies that can improve the lives of those with rare or difficult-to-treat diseases.